| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,742 |
1,614 |
$146K |
| 99070 |
|
1,884 |
1,731 |
$67K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
425 |
420 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
265 |
246 |
$19K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
116 |
116 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
42 |
38 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
152 |
141 |
$423.96 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
35 |
29 |
$140.76 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
13 |
$50.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$44.00 |
| 99000 |
|
12 |
12 |
$3.63 |
| 99401 |
|
93 |
84 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
27 |
27 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
168 |
85 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| 81003 |
|
27 |
26 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
125 |
120 |
$0.00 |
| 94760 |
|
53 |
49 |
$0.00 |